What is GW501516 Cardarine?

GW501516 or Cardarine acts as a pparδ-modulator (Activator of proliferation of Delta receptors). GW501516 Activates and stimulates the absorption of glucose in the tissues of skeletal muscles. In other words, GW501516 changes the energy preferences of the body from carbohydrates to fats.

The connection Cardarine was opened relatively recently, but the effect that produces the drug is very interesting. It has been proven by experience that GW501516 really makes it possible to improve athletic performance by strengthening the ability of muscles to work without fatigue. It is especially effective in training loads, and the closer the athlete approaches to the limit of his abilities, the better GW501516 works, warning the feeling of fatigue.

The work mechanism of GW501516 is associated with the impact on the process of energy production in the body. Thus, the substance increases the formation and then the oxidation of fats, which serve as an important source of energy during training. Also thanks to GW 1516 increases the speed of blood flow, resulting in a stable transport of lipids to the places of their splitting. In addition GW501516 affects the processes of carbohydrate metabolism.

Also GW501516 supports cardiovascular system: When using anabolic steroids, some of which increase the pressure, Cardarine allows to normalize its level.

Effects of GW501516:

Significant increase in endurance & very fast Recovery.

Advantages of Cardarine:

- No side effects with proper application;

- is not a catabolic;

- allows to burn fat and keep muscles;

- increases good and lowers bad cholesterol.

Research: Cardarine demonstrated stimulation of oxidation of fatty acids in men who are prone to fullness. GW501516 was proposed as a potential drug for the treatment of obesity.

GW501516 increases the intake of glucose in skeletal muscle tissues and increases the expression of muscle genes involved mainly in the utilization of lipids. This changes the metabolism in the body in order to use burnt fat to produce energy instead of carbohydrates or muscle protein. This allows obese patients to lose fat effectively without experiencing muscular catabolism or hunger problems that are associated with low blood sugar levels.

In rats treated GW501516, there was an increased metabolism of fatty acids in skeletal muscles and protection from the induced diet of obesity and diabetes of the second type. At macaques-rhesus with obesity, GW501516 increased the amount of lipoprotein high density (HDL) and reduced the level of lipoprotein very low density (VLDL). The mechanism of action by means of which agonists pparδ increase the number of lipoprotein of high density, is the result of reinforced expression of the ABCA1 cholesterol transporter.

Dosage of GW501616

Recommended Dosage - 20 mg per day.

Active Substance: {4-[({4-methyl-2-[4-(trifluoromethyl) phenyl]-1.3-thiazol-5-yl} methyl) sulfanyl] -2-methylphenoxy} acetic acid How to: Take 1 capsule once a day at meal time.